FDA issues Cephalon warning letter over Provigil marketing materials
The FDA has warned Cephalon that promotional materials for its sleep drug Provigil made misleading claims the drug could also ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.